| FREIR | Federal Research on Biological and Health Effects of Ionizing Radiation |
|---|---|
| FUMIR | 5-fluorouracil, mitomycin C, radiation |
| FUR | 5-fluorouracil and radiation; fluorouracil riboside; fluorouridine; follow-up report; furin membrane... |
| H&R | hysterectomy and radiation |
| ICRU | International Commission on Radiation Units and Measurements |
| root of lung | All the structures entering or leaving the lung at the hilum, forming a pedicle invested with the pleura; includes the bronchi, pulmonary artery and veins, bronchial arteries and veins, lymphatics, and nerves. Synonym: radix pulmonis. (05 Mar 2000) |
|---|---|
| middle lobe of right lung | It is located anteriorly between the horizontal and oblique fissures and includes lateral and medial bronchopulmonary segments. Synonym: lobus medius pulmonis dextri. (05 Mar 2000) |
| miliary lung infiltrate | <radiology> T tuberculosis / fungal disease, E eosinophilic granuloma, M metastases (thyroid, melanoma, choriocarcinoma, renal cell, breast), P pneumoconiosis, parasites, E embolism of oily contrast, S sarcoid, T tuberous sclerosis (12 Dec 1998) |
| miner's lung | Pneumonoconiosis from accumulation of carbon from inhaled smoke or coal dust in the lungs. See: pneumomelanosis. Synonym: collier's lung, melanedema, miner's lung. Origin: anthraco-+ G. -osis, condition (05 Mar 2000) |
| pig lung carbonyl reductase | <enzyme> Tetrameric carbonyl reductase; mw 24 kD; properties distinct from monomeric cr; it is mainly distributed in the mitochondria of the pig lung; exhibits very low substrate specificity for aromatic and aliphatic carbonyl compounds and catalyses the oxidation of secondary alcohols and aldehydes; activated 2-5 fold by fatty acids ddbj/embl/genbank d16511 Registry number: EC 1.1.1.- (26 Jun 1999) |
| pigment induration of the lung | A condition characterised by firmness of the lungs, and a brown colour associated with haemosiderin-pigmented macrophages in alveoli, consequent upon long-continued congestion due to heart disease. Synonym: pigment induration of the lung. (05 Mar 2000) |
| collier's lung | Pneumonoconiosis from accumulation of carbon from inhaled smoke or coal dust in the lungs. See: pneumomelanosis. Synonym: collier's lung, melanedema, miner's lung. Origin: anthraco-+ G. -osis, condition (05 Mar 2000) |
| welder's lung | Relatively benign form of pneumoconiosis, associated with welding, resulting from deposit of fine metallic particles in the lung. (05 Mar 2000) |
| coptic lung | Condition caused by the cloth lung. (05 Mar 2000) |
| mushroom-worker's lung | <chest medicine> Extrinsic allergic alveolitis caused by inhalation of spores of the mold Thermopolyspora polyspora, Thermoactinomyces vulgaris, Micropolyspora faeni or Micromonospora vulgaris from contaminated mushrooms under cultivation or mushroom compost. (22 Sep 2002) |
| costal surface of lung | The surface of each lung that lies in contact with the costal pleura. Synonym: facies costalis pulmonis. (05 Mar 2000) |
| postperfusion lung | <cardiology, chest medicine> A condition in which abnormal pulmonary function develops in patients who have undergone cardiac surgery involving the use of an extracorporeal circulation; now rare due to advances in perfusion technique and equipment. (05 Mar 2000) |
| cystic adenomatoid malformation of lung | <radiology> Only true pulmonary cystic disease of newborn, three X-ray types: multicystic, walls of varying thickness, multicystic, one large dominant thin-walled cyst, solid, mediastinal shift common, cysts often contain foetal lung fluid, Treatment: surgery Cf: congenital lobar emphysema (12 Dec 1998) |
| cystic adenomatoid malformation of lung, congenital | A developmental anomaly that usually becomes apparent in the neonatal period with progressive respiratory distress. This malformation is a focal pulmonary dysplasia characterised by a multicystic mass of terminal bronchiolar structures. Ccam is classified into 3 separate types (I, II, III) depending on cyst size. (12 Dec 1998) |
| heart and lung transplant | A surgical procedure which replaces a diseased heart and lungs with a healthy heart and lungs from a donor. They have been used in patients with primary pulmonary hypertension and isolated severe heart and lung disease. They are not recommended for those with associated systemic disorders such as diabetes or autoimmune illness. Those with liver and/or kidney disease are also not candidates. Long-term outcomes are still being studied. (27 Sep 1997) |